Cancer Treatment Centers of America investigated Cancer Treatment Centers of America (CTCA), a for-profit cancer center that consistently spent more on marketing each year than any other U.S. cancer center, and found that it promoted patient testimonials that deceptively touted atypical results. Some patient testimonials also promoted novel treatments, such as immunotherapy or targeted therapies based on genomic testing, without clearly and conspicuously disclosing their limitations, risks and relative rarity.


  • Filed complaint with FTC
  • CTCA added disclaimer to website


February 2

CTCA officially becomes City of Hope.

December 8

City of Hope, a nonprofit National Cancer Institute (NCI)-designated cancer research and treatment organization, announces it has entered into an agreement to acquire CTCA. The press release indicates the transaction is expected to close in early 2022 and that after close, City of Hope intends to convert CTCA to a nonprofit organization.

November 15

CTCA adds a disclaimer at the top of its Patient Stories webpage. The disclaimer states: “We understand that no two cancer patients are alike, and neither is their treatment journey. Each patient’s journey, though, has some common traits: strength, determination, persistence and sense of hope in the battle against cancer. Our patients inspire us every day. We tell their stories here, in their words, as a tribute to them.”

October 22 sends a complaint letter to the FTC urging it to reopen its investigation of CTCA and take appropriate enforcement action.

May 31

The FTC’s consent agreement with CTA expires.

May 31

The FTC enters into a consent agreement with CTCA that prohibits it from, among other things, using patient testimonials that misrepresent the typical experience of its patients.


The Latest